Survey
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
Funding News July 30, 2007 NEWS & NOTICES FOR THE WEEK ENDING July 27, 2007 NIH Requiring Electronic Financial Status Report System (FRS) Beginning October 1, 2007 [NOT-OD-07-078] (7/27) Requires all FSRs due on or after October 1 to be submitted via the electronic system in eRA Commons. Does not affect other Federal agencies. NIDCR Withdrawing from the NIH Small Research Grant Program [NOT-DE-07-004] (7/25) Effective immediately. NIDA Genetics Consortium Samples Available (7/23) Institute funds numerous human genetics research projects aimed at identifying the genes that confer susceptibility to drug abuse, drug addiction, and drug abuse-related behaviors. Access to primary data and biomaterials generated by these studies may be gained through the NIDA Center for Genetic Studies. See NOT-DA-07-019 for dates, etc. DHHS finds Research Misconduct at UCLA [NOT-OD-07-079] (7/27) Research Associate intentionally fabricated multiple interviews, urine samples, and urine sample records of human subject study participants of NIDA-funded study. FEDERAL SOLICITATIONS NCI/NINR/OBSSR/NIGMS/NIDCD Biobehavioral Methods to Improve Outcomes Research – R21 [PA-07-008] (10/13/06) Receipt Dates October 5, February 5, June 5 (standard R01) Closes September 2, 2008 Encourages methodological and technological innovation among biobehavioral studies that use cancer as the disease paradigm and seek to improve clinical outcome (e.g., quality of life, symptom management, disease progression). Research using innovative methods to study the interface between behavioral factors (e.g., stress, affect, coping), tumor biology (e.g., angiogenesis, T-cell regulation, inflammation, viral oncogenesis) and other biological mechanisms (e.g., apoptosis, DNA repair), and cancer control are appropriate. NCI/NHLBI/OBSSR/NINR/NIDDK Health Promotion Among Racial and Ethnic Minority Males – R01 [PA-07-422] (7/27) Receipt Dates October 5, February 5, June 5 (standard R01) Closes September 8, 2010 Seeks applications from applicants that propose to stimulate and expand research in the health of minority men. Goals • Enhance our understanding of the numerous factors (e.g., sociodemographic, community, societal, personal) influencing the health-promoting behaviors of racial and ethnic minority males and their subpopulations across the life cycle • Promote the development and testing of culturally and linguistically appropriate health-promoting interventions designed to reduce health disparities among racially and ethnically diverse males and their subpopulations age 21 and older NCI/NHLBI/OBSSR/NINR/NIDDK Health Promotion Among Racial and Ethnic Minority Males – R21 [PA-07-421] (7/27) Receipt Dates October 16, February 16, June 16 (standard R21) Closes September 8, 2010 See above. NICHD/NIMH Diagnostic and Pharmacokinetic Research in Pediatric HIV/TB and Effects of Co-infection on the Central Nervous System – R01 [RFA-HD-07-006 ] (7/23) LOI September 23, 2007 Receipt Date October 23, 2007 Closes October 28, 2007 Seeks applications from institutions/organizations that propose improved modalities for the diagnosis of tuberculosis (TB) infection and disease, including MDR and XDR TB, in children with HIV/TB co-infection. Applications are also invited for the evaluation of the pharmacokinetics of first- and second-line anti-tubercular medications, as well as pharmacokinetic drug interactions between these and antiretroviral medications in children with HIV/TB co-infection. Finally, applications are solicited for research to evaluate the effect of HIV/TB co-infection in children on the central nervous system. Intentions of Initiative • Stimulate research to improve the diagnosis and treatment of HIV-infected children with tuberculosis (TB) co-infection • Form a basis for future research and clinical care Commitment $1.9M for 3-6 applications NIGMS/NIDA/NIMH/NINDS/NIAID Exceptional, Unconventional Research Enabling Knowledge Acceleration (EUREKA) – R01 [RFA-GM-08-002] (7/23) LOI September 24, 2007 Receipt Date October 24, 2007 Closes October 25, 2007 Solicits applications from institutions/organizations proposing exceptionally innovative research on novel hypotheses or difficult problems, solutions to which would have an extremely high impact in biomedical or biobehavioral research that is germane to the mission of one or more of the participating NIH Institutes. Does not support pilot projects, i.e., projects of limited scope that are designed primarily to generate data that will enable the PI to seek other funding opportunities. Commitment Award Criteria Over 4 years, $8.4M total: $5M to fund 13-17 applications (NIGMS) + $3.4M (other Institutes combined) This funding opportunity is non-renewable. NIGMS Large-Scale Collaborative Project Awards – R24/U54 [PAR-07-412] (7/23) Receipt Dates Phase I: September 17, 2007-2009 2 Closes Phase II: June 17, 2008-2010 June 18, 2010 Re-announces the program of large-scale collaborative project awards (glue grants), last issued as PAR-04-128 in July, 2004. These awards are intended to solve critical, complex biological problems within the mission of NIGMS by supporting a team of independently funded investigators to synergize and integrate their research efforts. Award Requirements Phase I: $50K for 1 year Phase II: $25M over 5 years Large-scale collaborative project awards must include a PI, participating investigators, a steering committee, and an advisory committee. NHLBI/NICHD/NIDDK/NINR Lymphatic Biology in Health and Disease — R01 [PAR-07-420] (7/27) LOI August 27, 2007, August 16, 2008, and August 17, 2009 Receipt Dates September 28, 2007, September 18, 2008, and September 18, 2009 Closes September 19, 2009 Solicits applications from qualified researchers to investigate the biology of the lymphatic system and potential new therapeutic implications. Intentions of Initiative • Stimulate research on the biology of the lymphatic system at all biologic levels: molecular, cellular, tissue, organ, and whole body levels. • Include research on innovations for identifying and intervening in lymphatic diseases across all age groups and disease states. ADDITIONAL SOLICITATIONS • FIC International Research Ethics Education and Curriculum Development Award — R25 [RFA-TW-08-002] (7/26) • NICHD Mathematical Cognition and Specific Learning Disabilities — R01 [RFA-HD-07005] (7/23) • NIGMS/NCMHD Bridges to the Baccalaureate Program — R25 [PAR-07-411] (7/23) • NIGMS/NCMHD Bridges to the Doctorate Program — R25 [PAR-07-410] (7/23) • NICHD/NIGMS/NINDS/NIDA/NIEHS Developmental Pharmacology — R01 [PAR-07-416] (7/24) • NIDA/NIAAA Genetic Epidemiology of Substance Use Disorders — R01, R03, R21 [PA07-413 ] [PA-07-414 ] [PA-07-415] (7/24) • NIDCR Small Grant Program for New Investigators — R03 [PAR-07-418] (7/25) • NIBIB/NCCAM/NCRR/NEI/NIA/NIAAA/… Neuroimaging Informatics Software Enhancement for Improved Interoperability and Dissemination — R03 [PAR-07-417] (7/25) • NIMH Computational Tools for Research in Neuroscience, Behavioral Science, and Mental Health: STTR — R41/R42 [PA-07-423] (7/27) • NICHD Developmental Mechanisms of Human Structural Birth Defects — P01 [PA-07419] (7/27) PRIVATE FOUNDATION SOLICITATIONS José Carreras International Leukaemia Foundation Fellowship Receipt Date November 2, 2007 (by International mail) 3 For junior faculty, this fellowship funds research on the diagnosis, prevention, and cure of leukemia and related hematologic malignancies. Award Requirements Application Up to 3 years @ $50K a year • MD or PhD less than 10 years ago (first degree) • Devote 80% effort to project • Funding for Years 2 & 3 is conditional Paper Burroughs Wellcome Fund Clinical Scientist Awards in Translational Research Receipt Date August 15 (formerly Sept 1) Solicits innovative proposals that bring novel ideas and new approaches to translational research. Supports research that draws upon recently available discoveries in the basic biomedical sciences. No large-scale clinical trials. Brochure Advisory Committee 2007 Recipients Award Commitment Requirements Application $150K for up to 5 years 10 awards in 2008 • US citizen or permanent resident • MD or MD-PhD in clinical subspecialty • Assistant Prof or Associate Prof (preferably within 2 yrs of appt) • Current medial license • Established investigator • Nominated by institution • ProposalCentral (electronic) Burroughs Wellcome Fund Career Awards for Medical Scientists Receipt Date October 1, 2007 Bridges advanced postdoctoral fellowship training and the early stages of faculty service. The NIH Career Development Awards were modeled after this program. Postdoctoral portion lasts 1-2 years. Research can be basic biomedical, disease-oriented, translational, molecular genetic, or pharmacological epidemiology. Epidemiology researchers should contact BWF before applying. Brochure Advisory Committee Grant Recipients 4 Award Requirements Application $700K over 5 years (max of $95K postdoctoral years) • Clinical fellow, resident, instructor (non-tenure track) or postdoc • At least 2 yrs postdoctoral experience • Medical degree from US/CA institution (or lisence to practice in US/CA) • 75% effort to research-related activities • Nominated by institution (5 nominations each) • ProposalCentral (electronic) The American Society of Nephrology M. James Scherbenske Grant Receipt Date November 15, 2007, March 15, 2008, and June 15, 2008 Bridge funding for investigators whose competitive renewal R01s were scored but not funded. Application Recipients Award Restrictions $100K for 1 year (can include 10% indirect) • Active member (dues paid no later than Feb 1 of application year) • No more than $140K total extramural funding (direct costs) • MD, PhD or equiv degree • Full-time faculty • ≥ 75% time available research (all projects) Lymphoma Research Foundation Postdoctoral Fellowships Receipt Date September 4, 2007 Two-year fellowships designed to attract the nation's best scientific talent to careers in lymphoma and allow them to pursue promising leads under the guidance of a Sponsor. Guidelines Policy, Terms, and Conditions Award Requirements Application Year I: $50K, Year II: $55K • Must have completed 2 years of postdoctoral fellowship and not more than 2 years as junior faculty instructor or assistant professor • Must hold MD, PhD, or equiv., • Must secure unique sponsor who will supervise proposed research project. • Minimum of 80% effort in research without major patient care, teaching, or administrative responsibilities unless they relate directly to a pre-clinical or clinical lymphoma research project • Can’t hold another competitive fellowship title during LRF grant period. proposalCENTRAL (electronic) Lymphoma Research Foundation Career Development Awards (CDA) Receipt Date September 4, 2007 5 This three-year program funds training of clinicians who will participate in developing new therapeutics and diagnostic tools for lymphoma. Clinicians will be trained to design and administer clinical studies and to take on primary responsibility for trial design, protocol development, IRB submission, and publication. A Career Development Plan and the commitment of a mentor are required as part of the grant application. Guidelines Policy, Terms and Conditions Award Commitment Requirements Criteria $75K a year for 3 years 3 awards annually Applicants: 1. Must be licensed physicians at a clinical research institution in US/Canada 2. Should be advanced fellow or junior faculty up to the level of assistant professor - must also possess at least 2 years of training in hematology and/or oncology, plus clinical experience managing patients with lymphoma 3. Must have unique Primary Mentor who will oversee the applicant’s research training. 4. Clinical Investigator must spend at least 50% of time in research. 5. May not hold another competitively applied for fellowship or career development award during the period of the LRF Grant proposalCENTRAL (electronic). APPROACHING DEADLINES The following programs have been summarized in previous issues of Funding News, which are available on the Cancer Center website under Research/Grants/Summary Information. (Red indicates that an LOI or preapplication was required prior to the application date.) Due Date Program More Info Issue # August 8 – LOI Alliance for Cancer Gene Therapy (ACGT) Young Investigators Award 23 August 8 – LOI ACGT Investigators Award in the Clinical Translation of Gene Therapy for Cancer 23 August 8 PAR-07-384 20 August 10 NCCAM Ruth L. Kirschstein NRSA for Individual Predoctoral Fellowship Training in Complementary and Alternative Medicine – F31 CDC/OPHR Grants for Public Health Research Dissertations – R36 (LOI due 30 days prior) PAR-07-231 22 August 14 FIC/NCI/NIAAA/NIAID/NIDCR/NIDA/NINH/NINR/ORWH AIDS International Training and Research Program – D43 PAR-07-239 12 August 14 NIDCR Oral Mucosal Vaccination against HIV Infection – R01, R21 RFA-DE-08-003 RFA-DE-08-004 12 August 14 – LOI NIH Roadmap National Institutes of Health Rapid Access to Interventional Development (NIH-RAID Pilot) – X01 PAR-07-358 14 6 August 15 Burroughs Wellcome Fund (BWF) Clinical Scientists Awards in Basic Research 12 August 15 American Society of Clinical Oncology (ASCO) ACRA in Hematological Malignancies 21 August 17 August 17 – LOI NCRR High End Instrumentation Grant Program – S10 PAR-07-383 20 NCCAM/NCRR/NEI/NIAAA/NIA/NIBIB/NICHD… NIH Blueprint for Neuroscience Research Tools and Techniques for Elucidating and Manipulating Neural Circuit Development – R21 Lustgarten Foundation for Pancreatic Cancer Research RFA-MH-08-060 23 NIDA/NIEHS Mechanism for Time-Sensitive Research Opportunities – R21 (LOI due 1 month prior) PAR-07-345 11 August 20 – LOI NIDA/NIEHS Mechanism for Time-Sensitive Research Opportunities – R21 PAR-07-345 11 August 20 – LOI NHGRI A Data Analysis Center for the Encyclopedia of DNA Elements (ENCODE) Project – U01 RFA-HG-07-010 23 August 20 – LOI NICHD Population Research Infrastructure Program – R01 RFA-HD-07-009 22 August 21 Specialized Programs of Research Excellence (SPORES) In Human Cancer for the Year 2007 PAR-06-505 20 August 21 – LOI Specialized Programs of Research Excellence (SPOREs) in Human Cancer, 2007 – P50 PAR-06-505 1 August 21– LOI NIH FIC/NCI/NIA/NIBIB/NIEHS/NINDS/ODS Global Research Initiative Program, Basic/Biomedical Sciences – R01 PAR-07-239 10 August 24 Avon Foundation – Breast Cancer Prevention Research Initiative August 27 – LOI NIH NCI Application of Emerging Technologies for Cancer Research – R21, R33, SBIR(R43,R44), STTR(R41,42) RFA-CA-07-035 RFA-CA-07-036 RFA-CA-07-041 RFA-CA-07-042 3 August 27 – LOI NIH NCI Innovations In Cancer Sample Preparation – SBIR(R43,R44), STTR(R41,42) RFA-CA-07-043 RFA-CA-07-044 3 August 27 – LOI NIH NCI Innovative Technologies for Molecular Analysis of Cancer (IMAT) – R21, R33, SBIR(R43,R44), STTR(R41,42) RFA-CA-07-033 RFA-CA-07-034 RFA-CA-07-039 RFA-CA-07-040 3, 16 August 29 NIH NIGMS Molecular Probes for Microscopy of Cells – R01 PAR-07-234 9 August 31 Robert Wood Johnson Foundation Physician Faculty Scholars Program 20 Sept. 4 American Lung Association – Research Grants, Clinical Research Grants, Career Investigators; Training Awards, and 17 August 20 August 20 22 17 7 Alliance Awards Sept. 4 NIHM National NeuroADIS Tissue Consortium (NNTC) Data Coordinating Center (DCC) – U01 RFA-MH-08020 17 Sept 5. American Gastrological Association: Funderburg Research Research Scholar Award, Bridging Grant 19 Sept 6 – LOI Concern Foundation Conquer Cancer Now Award 18 Sept. 7 NCI/NBIB/NEI/NHLBI/NHGRI/NIA/NIAMS/NICHD/NIDA/NIDCD/ NIDCR/NIEHS/NINDS Bioengineering Research Partnerships – R01 Sept. 7 Standard AIDS-related applications due, including: • NIDA AIDS-Science Track Award for Research Transition (ASTART) – R03 PAR-07-352 12 PAR-07-347 12 RFA-HS-08-001 20 Sept. 10 – LOI AHRQ/OEREP National Research Service Award Institutional Research Training Grant – T32 Sept. 14 Cancer Research and Prevention Foundation (CRPF) Grants and Fellowship Program Sept. 14 NIH Roadmap National Institutes of Health Rapid Access to Interventional Development (NIH-RAID Pilot) – X01 PAR-07-358 14 Sept. 14 NCI / NCAAM Omics and Variable Responses to CAM: Secondary Analysis of CAN clinical Trials – R01, R21 PAR-07-378 19 Sept. 15 Cancer Research and Prevention Foundation CRPF Grants and Fellowships Program 4 Sept. 17 – Pre-app Leukemia and Lymphoma Society Career Development Program 19 Sept. 17 NCCAM/NCRR/NEI/NIAAA/NIA/NIBIB/NICHD… NIH Blueprint for Neuroscience Research Tools and Techniques for Elucidating and Manipulating Neural Circuit Development – R21 (LOI due 1 month prior) RFA-MH-08-060 23 Sept. 17 NCRR High-End Instrumentation Grant Program – S10 PAR-07-383 20 Sept. 18 – LOI NCI/NIAID/NHLBI/NIAAA/NICHD/NIDA/NIMH U.S.-India Bilateral Collaborative Research Partnerships (CRP) on the Prevention of HIV/AIDS – R21 RFA-AI-07-031 23 Sept. 19 NICHD Population Research Infrastructure Program – R01 RFA-HD-07-009 22 Sept. 19 NIH/OBSSR/NCCAM/NEI/NHLBI/NIAMS/NIAID/NICHD/NIDCR/N IDDK/NIEHS/NIGMS/NIMH/NINDS/NINR/NIA/NIAAA/NICHD/NID A/NILM/OPHR/(CDC) Behavioral and Social Science Research on Understanding and Reducing Health Disparities – R01, R21 PAR-07-379 PAR-07-380 19 Sept. 19 – LOI NIH/OBSSR/NCCAM/NEI/NHLBI/NIAMS/NIAID/NICHD/NIDCR/N IDDK/NIEHS/NIGMS/NIMH/NINDS/NINR/NIA/NIAAA/NICHD/NID A/NILM/OPHR/(CDC) Behavioral and Social Science Research on Understanding and Reducing Health Disparities – R01, R21 PAR-07-379 PAR-07-380 19 12 8 Sept. 19 – LOI NIDA/NIEHS Mechanism for Time-Sensitive Research Opportunities – R21 PAR-07-345 11 Sept. 20 NHGRI A Data Analysis Center for the Encyclopedia of DNA Elements (ENCODE) Project – U01 RFA-HG-07-010 23 Sept. 20 NIDA/NIEHS Mechanism for Time-Sensitive Research Opportunities – R21 (LOI due 1 month prior) PAR-07-345 11 Sept. 20 NIH Framework Programs for Global Health - R25 RFA-TW-08-001 15 Sept. 21 NIH FIC/NCI/NIA/NIBIB/NIEHS/NINDS/ODS Global Research Initiative Program, Basic/Biomedical Sciences – R01 PAR-07-239 10 Sept. 21 FIC/NCCAM/NIA/NIAAA/NIBIB/NIDCD/NIDCR/NIDA/NIEHS/NIN DS International Research Collaboration – Basic Biomedical (FIRCA-BB) – R03 PAR-07-335 10 Sept. 24 – LOI NIGMS Research on Interventions that Promote Research Careers R01 RFA-GM-08-005 19 Sept. 25 NIH NCI Cancer Education and Career Development Program – R25 PAR-06-511 3 Sept. 26 – LOI NIDA Criminal Justice Drug Abuse Treatment Studies 2 – U01 RFA-DA-08-002 22 Sept. 27 NIH NCI Application of Emerging Technologies for Cancer Research – R21, R33 RFA-CA-07-035 RFA-CA-07-036 3 Sept. 27 NIH NCI Innovative Technologies for Molecular Analysis of Cancer (IMAT) – R21, R33, SBIR(R43,R44), STTR(R41,42) RFA-CA-07-033 RFA-CA-07-034 3, 16 Sept. 28 NIH NCI Innovative Technologies for Molecular Analysis of Cancer (IMAT) –SBIR(R43,R44), STTR(R41,42) RFA-CA-07-039 RFA-CA-07-040 3, 16 Sept. 28 NIH NCI Application of Emerging Technologies for Cancer Research –SBIR(R43,R44), STTR(R41,42) RFA-CA-07-041 RFA-CA-07-042 3 Sept. 28 NIH NCI Innovations In Cancer Sample Preparation – SBIR(R43,R44), STTR(R41,42) RFA-CA-07-043 RFA-CA-07-044 3 Sept. 28 – LOI NHLBI Summer Institute Program to Increase Diversity in HealthRelated Research (SIPID) – R25 RFA-HL-07-012 17 Sept. 28 Beckman Foundation Beckman Young Investigator Program 21 Sept. 28 Louisiana Breast Cancer Task Force Health, Services, Education, and Outreach Grants 22 Oct. 1 Charlotte Geyer Foundation 13 Oct. 1 Wendy Will Case Cancer Fund 14 Oct. 1 Burroughs Wellcome Fund – Biomedical Scientists 18 Oct. 1 Parker B. Francis Fellowship in Pulmonary Research 19 Oct. 1 NCI Clinical Correlative Studies: Exploratory Studies in Cancer PA-05-165 15 9 Detection, Diagnosis and Prognosis – R21 Oct. 1 Leukemia and Lymphoma Society Career Development Program 19 Oct. 3 Alliance for Cancer Gene Therapy (ACGT) Young Investigators Award 23 Oct. 3 ACGT Investigators Award in the Clinical Translation of Gene Therapy for Cancer 23 Oct. 5 Standard R01 applications due Oct. 5 NHLBI Investigator Initiated Multi-Site Clinical Trials – R01 Oct. 8 Cancer Treatment Research Foundation Oct. 12 Standard Career Development (K) applications due, including: • NHLBI/NIDDK/NIAAA/NIEHS Career Enhancement Award for Stem Cell Research – K18 • NIH Pathway to Independence (PI) Award (K99/R00) PAR-07-373 19 16 PAR-07-358 PA-07-297 14 18 Oct. 15 American Cancer Society (ACS) • Cancer Control Career Development Awards for Primary Care Physicians • Postdoctoral Fellowships • Doctoral Training Grants in Oncology Social Work • Master's Training Grants in Clinical Oncology Social Work • Physician Training Awards in Preventive Medicine • Doctoral Degree Scholarships in Cancer Nursing 3S Oct. 15 ACS Mentored Research Scholar Grant in Applied and Clinical Research 2S Oct. 15 – LOI NCI-Avon “Progress for Patients” (PFP) Awards for Early Phase Clinical Interventions and Biomarkers in Breast Cancer (Limited Competitive Supplements [Revisions] for P30 Cancer Center Support Grants) PAR-07-244 10 Oct. 15 – LOI Oct. 15 Oct. 16 NIH Centers for Research to Reduce Disparities in Oral Health – U54 (Cooperative Agreement) Parker B. Francis Fellowships in Pulmonary Research Standard R03, R21, R33, R34, and R36 applications due RFA-DE-08-008 15 Oct. 16 NCI/ORWH/NEI/NHLBI/NHGRI/NIA/NIAA/NIAAA/NIAID/NIAMS/ NICHD/NIDCD/NIDCR/NIDA/NIEHS/NIGMS/NIMH/NINDS/NINR/ NLM/FIC/NICCAM/OBSSR/ODS Advancing Novel Science in Women’s Health Research (ANSWHR) - R21 (new apps) PAS-07-382 20 Oct. 16 NCI/ORWH/NEI/NHGRI/NIAAA/NIAMS/NICHD/NIDCR/NIDA/NIE HS/NIMH/NINDS/NLM/FIC/NICCAM/OBSSR/ODS Advancing Novel Science in Women’s Health Research (ANSWHR) – R03 (new apps) PAS-07-382 20 Oct. 16 American Liver Foundation Postdoctoral Research Fellowship Awards 21 Oct. 19 – LOI Thrasher Research Fund (clinical/translational pediatric research) 15 Oct. 18 NCI/NIAID/NHLBI/NIAAA/NICHD/NIDA/NIMH U.S.-India Bilateral Collaborative Research Partnerships (CRP) on the Prevention of 23 RFA-AI-07-031 23 10 HIV/AIDS – R21 (LOI due 1 month prior) Oct. 19 AHRQ/OEREP National Research Service Award Institutional Research Training Grant – T32 RFA-HS-08-001 20 Oct. 19 NIDA/NIEHS Mechanism for Time-Sensitive Research Opportunities – R21 (LOI due 1 month prior) PAR-07-345 11 Oct. 20 – LOI NIDA/NIEHS Mechanism for Time-Sensitive Research Opportunities – R21 PAR-07-345 11 Oct. 22 – LOI NIA/NICHD Studies to Identify Possible Juvenile Protective Factors and their Effects on Aging – R01 RFA-AG-08-003 23 Oct. 22 NIGMS Research on Interventions that Promote Research Careers R01 RFA-GM-08-005 19 Oct. 23 NIGMS/NIEHS Collaborative Studies on Systems Biology of Complex Phenotypes – R01 PAR-07-358 14 Oct. 26 Oct. 29 NIDA Criminal Justice Drug Abuse Treatment Studies 2 – U01 NHLBI Summer Institute Program to Increase Diversity in HealthRelated Research (SIPID) – R25 RFA-DA-08-002 RFA-HL-07-012 22 17 Oct. 29 – LOI NCI/NINR NINR Nursing Science Research on Interventions in Chronic Illness—P01 RFA-NR-08-001 20 Nov. 14 – LOI NIAAA Exploratory/Developmental Alcohol Research CentersP20 RFA-AA-08-003 22 Nov. 14 – LOI NIAAA Resource Core Alcohol Research Centers – P30 RFA-AA-08-004 22 Nov. 14 – LOI NIAAA Specialized Alcohol Research Centers – P50 RFA-AA-08-005 22 Nov. 14 – LOI NIAAA Comprehensive Alcohol Research Centers – P60 RFA-AA-08-006 22 Nov. 14 NCI/NCCAM Mechanisms of Immune Modulation – R01, R21 RFA-AT-07-004 RFA-AT-07-005 23 Nov. 15 NCI-Avon “Progress for Patients” (PFP) Awards for Early Phase Clinical Interventions and Biomarkers in Breast Cancer (Limited Competitive Supplements [Revisions] for P30 Cancer Center Support Grants) PAR-07-244 10 Nov. 15 NIH Centers for Research to Reduce Disparities in Oral Health – U54 (Cooperative Agreement) NCI/ORWH/NEI/NHLBI/NHGRI/NIA/NIAA/NIAAA/NIAID/NIAMS/ NICHD/NIDCD/NIDCR/NIDA/NIEHS/NIGMS/NIMH/NINDS/NINR/ NLM/FIC/NICCAM/OBSSR/ODS Advancing Novel Science in Women’s Health Research (ANSWHR) - R21 (resubmissions) RFA-DE-08-008 15 PAS-07-381 20 Nov. 16 NCI/ORWH/NEI/NHGRI/NIAAA/NIAMS/NICHD/NIDCR/NIDA/NIE HS/NIMH/NINDS/NLM/FIC/NICCAM/OBSSR/ODS Advancing Novel Science in Women’s Health Research (ANSWHR) – R03 (resubmissions) PAS-07-382 20 Nov. 19 NIA/NICHD Studies to Identify Possible Juvenile Protective Factors and their Effects on Aging – R01 RFA-AG-08-003 23 Nov. 16 11 Nov. 20 NIDA/NIEHS Mechanism for Time-Sensitive Research Opportunities – R21 (LOI due 1 month prior) PAR-07-345 11 Nov. 20 – LOI NIDA/NIEHS Mechanism for Time-Sensitive Research Opportunities – R21 PAR-07-345 11 Nov. 20 Thrasher Research Fund (clinical/translational pediatric research) (LOI due June 16) Nov. 26 NCI/NINR Nursing Science Research on Interventions in Chronic Illness—P01 Dec. 1 Concern Foundation Conquer Cancer Now Award 18 Dec. 1 – LOI Gerber Foundation Grants 15 Dec. 1 US Immunodeficiency Network (USIDNET) Grants Program 23 Dec. 5 Kimmel Foundation Translational Science Award 2S Dec. 5 Kimmel Foundation Kimmel Scholars Award for Cancer Research 20 Dec.8 NIH NCCAM Ruth L. Kirshstein NSRA for Postdoctoral Training in Complementary and Alternative Medicine – F32 Dec. 14 American Institute for Cancer Research (AICR) Investigator Initiated Grant (IIG) and Post-Doctoral Grant Award (PDA) Dec. 14 NIAAA Exploratory/Developmental Alcohol Research Centers – P20 (LOI due 1 month prior) RFA-AA-08-003 22 Dec. 14 NIAAA Resource Core Alcohol Research Centers – P30 (LOI due 1 month prior) RFA-AA-08-004 22 Dec. 14 NIAAA Specialized Alcohol Research Centers – P50 (LOI due 1 month prior) RFA-AA-08-005 22 Dec. 14 NIAAA Comprehensive Alcohol Research Centers – P60 (LOI due 1 month prior) RFA-AA-08-006 22 Dec. 15 NIH Roadmap National Institutes of Health Rapid Access to Interventional Development (NIH-RAID Pilot) – X01 PAR-07-358 14 Dec. 20 NIDA/NIEHS Mechanism for Time-Sensitive Research Opportunities – R21 (LOI due 1 month prior) PAR-07-345 11 Dec. 21 – LOI NIDA/NIEHS Mechanism for Time-Sensitive Research Opportunities – R21 PAR-07-345 11 15 RFA-NR-08-001 PAR-07-319 20 6 14 12 GENERAL INFORMATION○ Unless otherwise specified, for each program description summarized in Funding News, the following guidelines apply: • • Dollar amounts represent direct costs. • • • NIH R03 awards are up to of $200K over two years and are nonrenewable. • • Applicants/Institutions can submit more than one application. • • No institutional restrictions other than the general NIH standards apply. • For programs with multiple participating Institutes, the sponsoring Institute is underlined. • NIH R01 awards are for unspecified amounts that are dependant on available funding and the nature of applications received; they are renewable. NIH R21 awards are up to $275K over two years and are nonrenewable. NIH AIDS-related proposals are associated with the standard receipt dates May 7, September 7 and January 7. All applicants with the skills, knowledge and resources necessary to perform proposed research are eligible. Not every NIH Institute and Centers supports all types of funding mechanisms. For example, when co-sponsoring an initiative, NEIHS may offer both R01 and R03 award mechanisms, whereas NIE will offer only the former. In the table of Approaching Deadlines, dates in red indicate that a pre-application or LOI was due. ○ Applicable unless otherwise specified No. 24, July 30, 2007 Hope Oddo, Jonna Ellis, & Heidi Davis Office of Grants and Development [email protected] 13